Gliminyle MV Plus 3mg/500mg/0.3mg Tablet
Marketer
Erinyle Pharma
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Gliminyle MV Plus 3mg/500mg/0.3mg Tablet
Gliminyle MV Plus 3mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combined-drug therapy manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease necessitates discussion with your physician before commencing treatment. Consult your doctor before using this medication during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Gliminyle MV Plus 3mg/500mg/0.3mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gliminyle MV Plus 3mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Gliminyle MV Plus 3mg/500mg/0.3mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gliminyle MV Plus 3mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Gliminyle MV Plus 3mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gliminyle MV Plus 3mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gliminyle MV Plus 3mg/500mg/0.3mg tablets on an empty stomach.
How Gliminyle MV Plus 3mg/500mg/0.3mg Tablet works:
The tablet Gliminyle MV Plus, containing 3mg/500mg/0.3mg of three distinct antidiabetic agents, offers a combined approach to blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Gliminyle MV Plus 3mg/500mg/0.3mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Gliminyle MV Plus 3mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliminyle MV Plus 3mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Gliminyle MV Plus 3mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should not use this medication. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Gliminyle MV Plus 3mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gliminyle MV Plus 3mg/500mg/0.3mg Tablet :
Should you forget a Gliminyle MV Plus 3mg/500mg/0.3mg Tablet dose, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliminyle MV Plus 3mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently